SFE Investment Counsel Has $3.95 Million Holdings in Danaher Co. (NYSE:DHR)

SFE Investment Counsel boosted its position in shares of Danaher Co. (NYSE:DHR) by 2.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 17,227 shares of the conglomerate’s stock after buying an additional 357 shares during the period. SFE Investment Counsel’s holdings in Danaher were worth $3,954,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of DHR. Fort Pitt Capital Group LLC boosted its position in shares of Danaher by 3.2% during the 3rd quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock worth $66,194,000 after acquiring an additional 7,421 shares in the last quarter. Good Life Advisors LLC bought a new position in shares of Danaher in the 3rd quarter valued at $217,000. ORG Partners LLC raised its holdings in shares of Danaher by 1,212.8% during the 4th quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate’s stock worth $636,000 after buying an additional 2,559 shares in the last quarter. Harvest Portfolios Group Inc. boosted its stake in Danaher by 1.2% in the third quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock valued at $56,233,000 after buying an additional 2,465 shares in the last quarter. Finally, Generate Investment Management Ltd bought a new position in Danaher in the fourth quarter valued at about $8,044,000. 79.05% of the stock is owned by institutional investors.

Insider Activity at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 11.10% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

DHR has been the topic of a number of research analyst reports. Jefferies Financial Group reduced their price target on shares of Danaher from $285.00 to $260.00 and set a “buy” rating on the stock in a research note on Wednesday, January 29th. Wells Fargo & Company lowered their price objective on Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a research report on Thursday, January 30th. Raymond James restated a “market perform” rating on shares of Danaher in a report on Monday, February 3rd. Wolfe Research upgraded Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target on the stock in a report on Thursday, October 31st. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $277.00 target price (down from $299.00) on shares of Danaher in a research note on Thursday, January 30th. Seven investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $278.00.

Danaher Trading Up 0.3 %

DHR stock opened at $202.22 on Thursday. Danaher Co. has a one year low of $196.80 and a one year high of $281.70. The company has a market capitalization of $146.06 billion, a PE ratio of 38.30, a price-to-earnings-growth ratio of 2.68 and a beta of 0.83. The company’s 50 day moving average price is $230.49 and its two-hundred day moving average price is $250.28. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter last year, the business earned $2.09 earnings per share. As a group, analysts predict that Danaher Co. will post 7.67 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were paid a $0.27 dividend. This represents a $1.08 annualized dividend and a dividend yield of 0.53%. The ex-dividend date was Friday, December 27th. Danaher’s payout ratio is 20.45%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.